The transcriptional co-activator PCAF regulates cdk2 activity

Area of Science:

• Molecular Biology
• Cell Biology
• Biochemistry

Background:

• Cyclin-dependent kinases (cdks) are crucial regulators of cell cycle progression and transcription.
• Understanding the regulation of cdks, particularly cdk2, is vital for comprehending cell cycle control.

Purpose of the Study:

• To investigate the interaction between the transcriptional co-activator PCAF and cdk2.
• To elucidate the functional consequences of this interaction on cdk2 activity and cell cycle progression.

Main Methods:

• Co-immunoprecipitation to demonstrate PCAF-cdk2 interaction.
• In vitro kinase assays to assess cdk2 activity inhibition.
• Cell-based assays involving PCAF and cdk2 overexpression to study cell cycle arrest.
• Mass spectrometry to identify PCAF-mediated post-translational modifications of cdk2.

Main Results:

• PCAF directly interacts with cdk2, primarily during the S and G2/M phases.
• PCAF inhibits cyclin/cdk2 complex activity, a specific effect not observed with other cyclin/cdk pairs.
• Overexpression of PCAF leads to cell cycle arrest at S and G2/M phases, dependent on cdk2.
• PCAF acetylates cdk2 at lysine 33 (K33), a residue critical for ATP binding, thereby inhibiting kinase activity.

Conclusions:

• PCAF regulates cdk2 activity through two distinct mechanisms: disruption of cyclin/cdk2 complexes and direct acetylation of cdk2 at K33.
• These findings reveal a novel regulatory pathway for cdk2 activity, impacting cell cycle control.